Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Vijaya Chadaram"'
Autor:
Kimberly L. Blackwell, Sarah Bacus, Renee A. Welch, Erika Hamilton, Justin Favaro, Gretchen G. Kimmick, Judith Hopkins, P. Kelly Marcom, Bercedis L. Peterson, Vijaya Chadaram, Christina I. Herold
XLS file - 16K, Pulmonary and pleural effusions, pneumonitis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5bf3beb80e1a37fabde4ae5b4ab567b
https://doi.org/10.1158/1078-0432.22444086
https://doi.org/10.1158/1078-0432.22444086
Autor:
Kimberly L. Blackwell, Sarah Bacus, Renee A. Welch, Erika Hamilton, Justin Favaro, Gretchen G. Kimmick, Judith Hopkins, P. Kelly Marcom, Bercedis L. Peterson, Vijaya Chadaram, Christina I. Herold
Purpose: A phase II study of dasatinib, an inhibitor of multiple oncogenic tyrosine kinases including Src, was conducted to evaluate 16-week progression-free rate and tolerability in patients with previously treated metastatic breast cancer (MBC). Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35626b66f610a4abdadbd2105d7447df
https://doi.org/10.1158/1078-0432.c.6520056
https://doi.org/10.1158/1078-0432.c.6520056
Autor:
Sophie Dessureault, Vijaya Chadaram, Timothy M. Clay, Michael A. Morse, Donna Niedzwiecki, David S. Hsu, Mebea Aklilu, Robert Annechiarico, David Z. Chang, Christopher R. Garrett, David J. Cole, Takuya Osada, Mark W. Onaitis, Amy Hobeika, Todd S. Crocenzi, Bryan M. Clary, Anuradha Bulusu, John L. Marshall, H. Kim Lyerly, Gayathri R. Devi
Publikováno v:
Annals of Surgery. 258:879-886
To determine whether 1 of 2 vaccines based on dendritic cells (DCs) and poxvectors encoding CEA (carcinoembryonic antigen) and MUC1 (PANVAC) would lengthen survival in patients with resected metastases of colorectal cancer (CRC).Recurrences after com
Autor:
Erika Hamilton, Sarah S. Bacus, Christina I. Herold, Justin Favaro, P. Kelly Marcom, Bercedis L. Peterson, Renee Welch, Kimberly L. Blackwell, Gretchen Kimmick, Vijaya Chadaram, Judith O. Hopkins
Publikováno v:
Clinical Cancer Research. 17:6061-6070
Purpose: A phase II study of dasatinib, an inhibitor of multiple oncogenic tyrosine kinases including Src, was conducted to evaluate 16-week progression-free rate and tolerability in patients with previously treated metastatic breast cancer (MBC). Re
Autor:
William G. Kraybill, Wendy R. Cornett, Rebecca P. Petersen, Douglas L. Fraker, Vijaya Chadaram, Douglas S. Tyler, Paul F. Mansfield, James E. Herndon, R. Dirk Noyes, Jeffrey E. Lee, Merrick I. Ross, David J. Winchester, James F. Pingpank, Linda M. McCall, Jeffrey J. Sussman, H. Richard Alexander, John M. Kane, Richard L. White, Henry A. Briele
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 24(25)
Purpose To determine in a randomized prospective multi-institutional trial whether the addition of tumor necrosis factor alpha (TNF-α) to a melphalan-based hyperthermic isolated limb perfusion (HILP) treatment would improve the complete response rat